ABOUT US
Assoc. Prof. Joachim Loo
Founder
Joachim is an Associate Professor in NTU with close to twenty years of experience and expertise in designing and developing drug delivery technologies for controlled release. He is Principal Investigator of several grants that led to this patented floating microcapsule technology. Published more than 190 papers and filed sixteen patents with seven of these granted in various countries. Has also developed a radioactive drug delivery system in collaboration with the International Atomic Energy Agency (IAEA), United Nations, and is co-convenor of the ISO-TC229 – Nanotechnology (Health and Safety) Committee.
Sashi Kesavapany
Co-Founder & CEO
Sashi has 18 years post PhD experience in target and disease biology. After two postdoctoral stints in KCL and at the NIH, he moved his neurodegenerative R&D into translational models of disease of Alzheimer’s disease and Neuroinflammation. He was an Assistant Prof in NUS until 2009. He then headed in vitro, in vivo and pharmacological teams in the GlaxoSmithKline R&D site in Biopolis, working on a number of programs in the R&D portfolio including Alzheimer’s disease, Parkinson’s disease, Amyotrophic Lateral Sclerosis, Huntington’s disease and SMA. He has routinely managed hitID and in vivo PK/PD experiments that progress molecules through the drug discovery pipeline.
Kaarunya Sampathkumar
Senior Scientist
Kaarunya is a Research Fellow in the research team led by A/Prof Joachim Loo in the School of Materials Science and Engineering at NTU. She has a Master’s degree in Medical Nanotechnology from SASTRA University, India and received her Ph.D. from NTU. Her main research interest is in the encapsulation and controlled delivery of active ingredients using micro/nanoparticles using both synthetic and natural polymers for oral delivery and her expertise lies in the gastro retentive drug delivery system for Parkinson’s disease and other indications.